selected publications
- Use of Leishmania major parasites expressing a recombinant Trypanosoma cruzi antigen as live vaccines against Chagas disease. Frontiers in microbiology. 2022 Academic Article GET IT
- High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era. Journal of virus eradication. 2021 Academic Article GET IT
-
Th17 Cells Provide Mucosal Protection against Gastric Trypanosoma cruzi Infection.
Infection and immunity.
2021
Academic Article
GET IT
Times cited: 5 -
Residual immune dysfunction under antiretroviral therapy.
Seminars in immunology.
2021
Review
GET IT
Times cited: 17 -
Inflammatory Biomarkers Do Not Differ Between Persistently Seronegative vs Seropositive People With HIV After Treatment in Early Acute HIV Infection.
Open forum infectious diseases.
2020
Academic Article
GET IT
Times cited: 2 -
Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi.
PLoS pathogens.
2016
Academic Article
GET IT
Times cited: 66